Market Signal Briefing

The XRP price continues to consolidate within a descending channel as investors assess upcoming catalysts. The chart highlights a structure similar to the July breakout that produced a strong rally. Meanwhile, anticipation builds around the SEC’s October deadlines for multiple XRP ETF filings. Market participants are preparing for heightened activity as technical patterns and regulatory events converge in the weeks ahead.

XRP Price Eyes Breakout From Descending Channel
The XRP price has been testing the boundaries of a descending channel, mirroring the setup observed before the July breakout. 

The July move resulted in a 66% rally, showing how this zone can trigger rapid surges once resistance cracks. The current XRP market price trades at $2.85, keeping it near the breakout threshold that could invite fresh buying. 

The Fib extensions project potential upside targets, with the 1.618 level at $3.48 and the 2.618 level at $3.97. However, the more immediate projection shows a 35% rally pointing directly toward $4 if the channel breaks this month. 

This mirrors the July performance and strengthens the case for another surge. Notably, support at $2.75 has cushioned recent declines, keeping bulls engaged. With pressure mounting against the upper channel boundary, XRP price looks primed for decisive movement in October.

XRP/USDT 1-Day Chart (Source: TradingView)
SEC ETF Decisions Could Amplify Moves
The SEC is set to decide on six spot XRP ETF applications in October, a lineup that could heavily shape short-term price direction. The first comes on October 18 with the Grayscale XRP ETF, which may inject early volatility depending on the outcome. 

A day later, October 19, focus will shift to the 21Shares Core XRP Trust, where approval could strengthen confidence in XRP’s institutional appeal. On October 20, the Bitwise XRP ETF will be reviewed, with expectations that a green light may draw fresh inflows. 

Meanwhile, October 23 brings the Canary Capital XRP ETF deadline, testing whether bullish pressure can sustain near key resistance levels. The week concludes October 25 with the WisdomTree XRP ETF, where a positive ruling could act as the final catalyst for October’s trading. 

With the chart projecting a possible 35% rally toward $4 by month’s end, the alignment of decisions with technical patterns feels crucial. Therefore, October activity could directly determine whether XRP finally clears its descending channel or delays another leg higher.

Summary
The XRP price faces a critical October as both technical and regulatory factors align. A channel breakout would mirror July’s explosive rally and open the path to $4. Multiple SEC decisions on ETFs may either fuel this breakout or reinforce resistance barriers. Overall, October’s outcomes could mark the turning point that defines XRP’s trajectory into year-end.

Frequently Asked Questions (FAQs)

The July breakout delivered a 66% rally, and the current setup mirrors that structure, hinting at another potential move.

October aligns with SEC ETF deadlines and a bullish technical setup, making it a critical period for XRP.

ETF approvals could expand institutional exposure, strengthen market legitimacy, and boost XRP’s long-term adoption prospects.

The phrase “Uptober” has gained popularity in the crypto market, as October has historically delivered gains in the past. For the XRP price, however, the picture looks very different. A closer look at its history shows a mix of big wins and painful losses, making October far less predictable. 

Removing the extreme years shows that the data points to flat or negative results, which means investors counting on an explosive rally may end up disappointed. Although the last quarter of the year has brought substantial gains in some cases, the overall record remains inconsistent, suggesting that “Uptober” may be more of a myth than a promise for XRP holders.

Historical Data Challenges The “Uptober” Hype For XRP Price
Every October, the crypto community hopes that coins will rise, and while Bitcoin sometimes lives up to this expectation, XRP’s history tells a different story. Data from CryptoRank shows that XRP has experienced some notable fluctuations in October over the last decade. In 2013, the token soared by more than 94%. In 2014, it jumped 130%. In 2020, it even delivered an explosive rally of nearly 179% in just one month.

Source: CryptoRank
But these massive rallies are rare. In many other years, the results were disappointing. For example, the XRP price suffered double-digit losses in October of 2018 and 2021. In other years, gains were delivered only in tiny amounts, far below what traders had hoped for. Stripping away the highs and lows makes the overall trend clear. The median October return for XRP is actually a slight loss of 1.79%, and the average return is even worse at -4.58%.

This data suggests that October is far more likely to bring disappointment than explosive growth for XRP holders. While the idea of “Uptober” may sound exciting, the history of XRP shows its performance in October is scattered, unpredictable, and often hostile. 

Q4 Patterns Show Risk Of Relying On Seasonal Myths
Some traders argue that even if October is not always a great month, the XRP price usually performs well in the final quarter of the year. Indeed, the last quarter has sometimes delivered big rallies, and the average Q4 return for XRP is nearly 88%. But these results are heavily skewed by a few extraordinary years. When the numbers are balanced, the median return for Q4 is actually a loss of 4.32%.

The negative median Q4 return shows that the perception of Q4 strength is not as reliable as many believe. The standout rallies do not represent the typical outcome. Instead, most years end up modest or even negative. The pattern points to risk, not certainty, for those who assume every Q4 will bring green candles.

Past data proves that while extraordinary runs are possible, they are rare, and the more common result is far less exciting. XRP could still surprise to the upside, but history warns against treating October as a guaranteed month of gains. Believing the hype without considering the risks may leave investors unprepared for disappointment.

Price fails to reclaim $3 | Source: XRPUSDT on Tradingview.com
Featured image created with Dall.E, chart from Tradingview.com

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Bulls are more powerful than bears today, according to CoinStats.

Top coins by CoinStatsBTC/USDThe rate of Bitcoin (BTC) has gone up by 2.6% over the past day.

Image by TradingViewOn the hourly chart, the price of BTC has made a false breakout of the local resistance of $112,438. However, if the daily bar closes near that mark or above it, bulls may seize the initiative, which may lead to a test of the $113,000 zone.

Image by TradingViewOn the longer time frame, the rate of BTC is far from the support and resistance levels. In this case, one should pay attention to the daily candle's closure in terms of yesterday's bar's peak. 

You Might Also Like

If it breaks out, the upward move is likely to continue to the $114,000 area.

Image by TradingViewFrom the midterm point of view, none of the sides is dominating. Thus, the volume is low, confirming the absence of buyers and sellers' energy. In this case, ongoing sideways trading in the range of $110,000-$114,000 is the more likely scenario.

Bitcoin is trading at $112,167 at press time.

SYDNEY, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dandelion Payments, a Euronet Worldwide, Inc. (NASDAQ: EEFT) company, has entered a strategic agreement with Commonwealth Bank of Australia (CBA), marking a significant milestone in CBA’s commitment to delivering faster, more transparent, and customer-centric international payment solutions.

Through a single integration with Dandelion, CBA customers will gain access to an expansive global infrastructure, enabling seamless transfers to recipients across a wide range of countries. The integration will deliver:

Real-time payment tracking and status updates via CBA’s digital channels, enhancing transparency and reducing uncertaintyInstant payouts to many jurisdictions, with future expansion to include digital wallets and cash pickup options, broadening customer choiceImproved customer experience, with faster transaction processing and reduced frictionEnhanced compliance and security, including robust pre-validation features such as account status checks and beneficiary name matching This agreement complements CBA’s existing correspondent banking network by expanding reach and improving speed in corridors where traditional methods may be slower or less accessible. It reflects CBA’s ongoing commitment to innovation and excellence in financial services, and positions the bank at the forefront of modernising cross-border payments.

About Dandelion

Dandelion is the world’s largest real-time, cross-border payments network, providing a complete payments-as-a-service solution. Dandelion’s global disbursements network comprises direct-to-local connections in 200 countries and territories, with built-in settlement, compliance, and full-value delivery. Through a single API integration or Swift instruction, Dandelion enables financial institutions, payment companies and fintechs to reach 4 billion+ bank accounts, 126 mobile wallets, 3 billion+ mobile wallet accounts, and 626K cash pickup locations. Visit www.dandelionpayments.com for more information. Dandelion is part of the money transfer segment of Euronet (NASDAQ: EEFT), a global leader in payments processing and cross-border transactions. Visit www.euronetworldwide.com for more information.

About CommBank

The Commonwealth Bank (ASX:CBA) is one of Australia’s leading providers of personal banking, business and institutional banking and share broking services. With more than 18 million customers and a history spanning more than a century, the Group’s purpose is to build a brighter future for all. The Commonwealth Bank is Australia’s leader in digital banking and maintains the largest branch network across the country. Headquartered in Sydney, Australia, the Bank operates brands including Bankwest in Australia and ASB in New Zealand. For more information on Commonwealth Bank, visit www.commbank.com.au.

©2025 Commonwealth Bank of Australia ABN 48 123 123 124 AFSL and Australian credit licence 234945

Media Contacts

CBA
P. 02 9595 3219 
E: [email protected]

Dandelion
Maria Colella
[email protected]

September 29, 2025 09:00 ET

 | Source:

Leggett & Platt, Incorporated

Carthage, MO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Leggett & Platt (NYSE:LEG), a diversified manufacturer of engineered products serving several major markets, will release third quarter earnings results on Monday, October 27, 2025 after the market closes, and hold its quarterly conference call to discuss third quarter results, annual guidance, market conditions, company initiatives, and related matters on Tuesday, October 28, 2025, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

This call will be webcast and can be accessed from the Investor Relations section of Leggett & Platt’s website at www.leggett.com. The earnings release and slides containing summary financial information will be posted to the Investor Relations section of our website on October 27 shortly after the market closes. The audio replay of the webcast and transcript will be available on our website after completion of the call and will remain available for 12 months.

COMPANY DESCRIPTION: Leggett & Platt (NYSE: LEG) is a diversified manufacturer that designs and produces a broad variety of engineered components and products that can be found in many homes and automobiles. The 142-year-old Company is a leading supplier of bedding components and private label finished goods; automotive seat comfort and convenience systems; home and work furniture components; geo components; flooring underlayment; hydraulic cylinders for material handling and heavy construction applications.

INVESTOR CONTACTS:  
Steve West, Vice President, Investor Relations
Katelyn J. Pierce, Analyst, Investor Relations
(417) 358-8131
[email protected]

September 29, 2025 09:00 ET

 | Source:

NeOnc Technologies Holdings, Inc.

CALABASAS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced it has appointed Dr. Henry S. Friedman to its scientific advisory board. Dr. Friedman is an internationally renowned academic adult and pediatric neuro-oncologist who helps to lead The Preston Robert Tisch Brain Tumor Center at Duke University. He is the author of more than 500 peer reviewed articles, reviews, and book chapters and has presented extensively at both international and national meetings.

“We are incredibly honored to welcome Dr. Henry Friedman, a true luminary in the field of neuro-oncology, to our scientific advisory board,” said Amir F. Heshmatpour, Executive Chairman and President of NeOnc Technologies. “His profound experience in developing novel therapies for CNS cancers and his distinguished career at Duke’s Preston Robert Tisch Brain Tumor Center will be invaluable as we advance our pipeline, including our lead candidates NEO100™ and NEO212™.

Mr. Heshmatpour added, “As NeOnc prepares to publish upcoming data from our NEO100 and NEO212 clinical programs, we look forward to our key opinion leaders carefully reviewing and validating these results. We believe their independent expertise will not only strengthen the confidence of our stakeholders but will also mark a turning point—one of destiny—for patients and families battling glioblastoma and other brain cancers. Together, with the guidance of leaders like Dr. Friedman, we are committed to changing the future for those who need it most.”

Henry S. Friedman, MD, Duke University
Henry S. Friedman is a senior neuro-oncologist at Duke and longtime leader at The Preston Robert Tisch Brain Tumor Center, where he serves as a deputy director and holds the James B. Powell, Jr. Distinguished Professorship in the School of Medicine. He cares for adult and pediatric patients at the Duke Cancer Center’s Brain Tumor Clinic and is an internationally renowned authority in neuro-oncology, with a publication record exceeding 500 peer-reviewed works and decades of national and international presentations. His work has spanned clinical trials and translational research across high-grade glioma, medulloblastoma, and ependymoma, helping to shape modern standards for difficult central nervous system (CNS) tumors. He has offered sustained leadership to one of the field’s best-known programs and ongoing engagement with collaborative, multi-center research efforts.

ABOUT NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s NEO100™ and NEO212™ therapeutics are in Phase II human clinical trials and are advancing under FDA Fast-Track and Investigational New Drug (IND) status. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.
For more about NeOnc and its pioneering technology, visit neonc.com.

Important Cautions Regarding Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “intend,” “expect,” “plan,” “budget,” “forecast,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “evaluating,” or similar words. Statements that contain these words should be read carefully, as they discuss our future expectations, projections of future results of operations or financial condition, or other forward-looking information. Examples of forward-looking statements include, among others, statements regarding whether a definitive agreement will be reached with Quazar. These statements reflect our current expectations based on information available at this time, but future events may differ materially from those anticipated.

The “Risk Factors” section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, along with other cautionary language in that report or in our subsequent filings, outlines important risks and uncertainties. These may cause our actual results to differ materially from the forward-looking statements herein, including but not limited to the failure to finalize the agreement with Quazar, modifications to its terms, or alternative uses of proceeds.

We assume no obligation to revise or update any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable securities laws and regulations.

“NEO100” and NEO “212” are registered trademarks of NeOnc Technologies Holdings, Inc.

Company Contact:
[email protected]

Investor Contact:
James Carbonara
Hayden IR
(646)-755-7412
[email protected]

SummaryDell Technologies Inc. expects FY26 revenue between $105–109 billion, with ISG driving growth through accelerated AI adoption and enterprise-scale deployments.AI server shipments are projected to double year-over-year, surpassing $20 billion, supported by an $11.7 billion backlog and expanding pipeline.DELL management anticipates ISG margins to improve in the second half as value engineering and stronger enterprise adoption take hold.The Windows 10 end-of-life refresh, impacting hundreds of millions of PCs, is set to fuel CSG demand through FY27.DELL stock’s forward P/E of 13.7x reflects rising earnings power, supported by FY26 EPS guidance of $9.55, up 17% year-over-year. Oselote/iStock via Getty Images

When I first published my first bullish call on Dell Technologies Inc. (NYSE:DELL) in March, I illustrated why the market was undervaluing the company's transformation into an AI infrastructure giant. Since then, the stock is up

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Key Takeaways Methanex partners in ARA and South Korea to expand methanol bunkering operations.TankMatch, Alpha Maritime and Hyodong Shipping support new bunkering services.The company leverages supply chain and safety expertise to meet rising methanol demand.
Methanex Corporation (MEOH - Free Report) recently announced new strategic partnerships, expanding methanol bunkering arrangements in two key maritime fueling hubs, the ARA (Amsterdam–Rotterdam–Antwerp) region and South Korea.

The company is collaborating with TankMatch in the ARA region to provide barge-to-ship methanol bunkering, building on an arrangement previously made between OCI Global and UniBarge, which it acquired through the OCI purchase. In South Korea, Methanex is partnering with Alpha Maritime and Hyodong Shipping to enable last-mile bunkering operations.

These partnerships strengthen the company’s role in leading the marine energy transition, allowing safe and reliable methanol fueling of two of the world’s busiest trade corridors. Leveraging MEOH’s expertise in local bunkering operators, combined with the reliable global supply chain, it will be able to provide a fully integrated and end-to-end methanol fuel solution. Methanex has also developed a comprehensive safety package and technical guidance for bunkering operators and shipping companies by utilizing its experience with methanol-fueled tankers operated through subsidiary, Waterfront Shipping.

As demand for low-carbon methanol rises, Methanex continues to expand its logistics and supply chain to meet regulatory requirements, enabling the best shipping standards. The partners have also expressed confidence in this new arrangement and are looking forward to bringing their expertise to the table.

MEOH’s shares have lost 2% over the past year compared with the industry’s 27.3% decline.

Image Source: Zacks Investment Research

MEOH’s Zacks Rank & Other Key PicksMEOH currently sports a Zacks Rank #1 (Strong Buy).

Other top-ranked stocks in the Basic Materials space are Agnico Eagle Mines (AEM - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and The Mosaic Company (MOS - Free Report) . AEM sports a Zacks Rank #1, while CRS and MOS carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for AEM’s current-year earnings is pegged at $7.11 per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 10.03%. AEM’s shares have risen 105.9% in the past year.

The Zacks Consensus Estimate for CRS’ current fiscal-year earnings is pegged at $9.51 per share, indicating a 27.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.38%. CRS’ shares have surged 57.9% in the past year.

The Zacks Consensus Estimate for MOS’ 2025 earnings is pegged at $3.17 per share, indicating a rise of 60.10% from year-ago levels. The company’s earnings beat the consensus estimate in one of the trailing four quarters while missing it in the rest. MOS’ shares have gained 35.8% in the past year.

Vibativ ®  treats patients with pneumonia and serious skin infections

, /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East and Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the launch of Cumberland's Vibativ® (telavancin) injection in Saudi Arabia.

Tabuk Pharmaceutical Manufacturing Company and Cumberland Pharmaceuticals Inc. announced the launch of Cumberland’s Vibativ® (telavancin) injection in Saudi Arabia.

The announcement follows an agreement between the companies providing Tabuk with the exclusive rights to register and promote the product for patients in Saudi Arabia and other countries in the Middle East.

Vibativ is a patented, FDA-approved injectable anti-infective that can serve as a potentially life-saving treatment in patients with hospital-acquired and ventilator-associated pneumonia resulting from infections, including the flu and COVID-19. It is intravenously administered with once-daily dosing and does not require therapeutic drug monitoring, decreasing health care professionals' exposure to the patient. It is designed to treat serious infections due to Staphylococcus aureus (S. aureus) and other Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Methicillin-sensitive Staphylococcus aureus (MSSA). Vibativ addresses a range of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant.

"Given the global concern about multidrug-resistant organisms, Vibativ is an important addition to our anti-infective portfolio and supports our mission to deliver unique health solutions and save the lives of people throughout the Middle Eastern countries we operate in," said Ismail Shehadah, CEO of Tabuk. "We believe Vibativ will provide our physicians with a powerful new tool to battle multidrug-resistant infections and we are excited to launch the product in Saudi Arabia."

According to a recent report from the World Health Organization, antimicrobial resistance (AMR) is an urgent global health and socioeconomic crisis. Further, the global rise in antibiotic resistance poses a significant threat, diminishing the efficacy of many common antibiotics against widespread bacterial infections.

Unlike many recently introduced antibiotics that are quickly losing the battle to fight the bacteria they were designed to kill because those bacteria have become drug-resistant, Vibativ was specifically designed to kill drug-resistant bacteria. The molecule of an existing antibiotic to which bacteria had developed a resistance, vancomycin, was altered by adding a lipophilic (fat-loving) component and a hydrophilic (water-loving) component. The lipophilic addition increases Vibativ's ability to penetrate the cell wall and inhibits the formation of new cell walls (the development of new and/or additional cell walls is the most common way that bacteria become resistant to drugs). The hydrophilic addition increases Vibativ's penetration into tissue, and is able to attack infections that are not reachable by other antibiotics.

Studies show that Vibativ is just as potent today against difficult-to-treat and multidrug-resistant bacteria as it was when it was introduced over 10 years ago.

"We are very pleased to expand the reach of Vibativ – an important and potentially life-saving drug – through this partnership with Tabuk," said A.J. Kazimi, CEO of Cumberland Pharmaceuticals. "We are confident that Tabuk has the resources and experience to ensure Vibativ reaches as many patients in Saudi Arabia as possible."

About Vibativ®

Vibativ® (telavancin) injection was discovered in a research program dedicated to finding new antibiotics for serious infections due to Staphylococcus aureus (S. aureus) and other Gram-positive bacteria, including MRSA and MSSA. Vibativ is a once-daily, injectable lipoglycopeptide antibiotic with in vitro potency, bactericidal activity within six hours and penetration into target infection sites. The drug is approved in the U.S. and Saudi Arabia for the treatment of adult patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of S. aureus when alternative treatments are not suitable.

In addition, Vibativ is approved in the U.S. and Saudi Arabia for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of Gram-positive bacteria, including S. aureus, both methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains. The product labeling also describes the use of Vibativ in treating patients whose pneumonia or skin infection is complicated by concurrent bacteremia. The product's proven efficacy against difficult-to-treat Gram-positive infections has been demonstrated in several large, multinational registrational studies, which involved one of the largest cohorts of patients with S. aureus infections studied to date. Importantly, these studies demonstrated significantly higher cure rates for Vibativ as compared to vancomycin in HABP/VABP due to any single Gram-positive pathogen or S. aureus with vancomycin MIC ≥1 µg/mL. Additionally, there is extensive and well-documented evidence of the drug's in vitro potency and in vivo activity against a broad collection of Gram-positive bacterial pathogens, including those that are considered difficult-to-treat and multidrug-resistant.

For full prescribing information, including important safety information, visit www.vibativ.com.

About Tabuk Pharmaceutical Manufacturing Co.

Tabuk Pharmaceutical Manufacturing Company is a leading Saudi pharmaceutical company with a regional presence in the Middle East and North Africa. Tabuk Pharmaceuticals develops, manufactures, markets and distributes various pharmaceutical products, in addition to manufacturing pharmaceutical products for renowned international partners at its manufacturing sites in Saudi Arabia, as part of its continuous efforts to cover the needs of patients by providing high quality medicines. Tabuk Pharmaceuticals is a major player in the pharmaceutical sector not only in the Kingdom of Saudi Arabia, but also throughout the Middle East and North Africa, thanks to its four state-of-art manufacturing sites located in Tabuk and Dammam in the Kingdom, as well as in Sudan and Algeria, and orchestrated by a team of more than 2,400 employees. Tabuk Pharmaceuticals reaches patients in 17 countries in the Middle East and Africa, in addition to futuristic plans to expand its presence in the region.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is the largest biopharmaceutical company founded and headquartered in Tennessee and is focused on providing unique products that improve the quality of patient care. The company develops, acquires, and commercializes products for the hospital acute care, gastroenterology and oncology market segments. The company's portfolio comprises six FDA-approved brands. The company also has a series of Phase II clinical programs underway evaluating its ifetroban product candidate in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy, Systemic Sclerosis and Idiopathic Pulmonary Fibrosis.

For more information, visit www.cumberlandpharma.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. Forward-looking statements include, among other things, statements regarding the company's intent, belief or expectations, and can be identified by the use of terminology such as "may," "will," "expect," "believe," "intend," "plan," "estimate," "should," "seek," "anticipate," "look forward" and other comparable terms or the negative thereof. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's operation results. These factors include macroeconomic conditions, including rising interest rates and inflation, competition, an inability of manufacturers to produce Cumberland's products on a timely basis, failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, natural disasters, public health epidemics, maintaining an effective sales and marketing infrastructure, and other events beyond the company's control as more fully discussed in its most recent annual report on Form 10-K as filed with the U.S. Securities and Exchange Commission (SEC), as well as the company's other filings with the SEC from time to time.

There can be no assurance that results anticipated by the company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.

SOURCE Cumberland Pharmaceuticals Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

SAN DIEGO, CALIFORNIA - MAY 3: Shoppers stand in line at a Nike outlet store on May 3, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Getty Images

Nike (NYSE: NKE) is set to publish its fiscal first-quarter earnings (for the May fiscal year) on Tuesday, September 30, 2025, with analysts expecting earnings of 26 cents per share on $10.99 billion in revenue. This would signify a 63% year-over-year decrease in earnings and a 5% decline in sales in comparison to the previous year’s figures of $0.70 per share and $11.61 billion in revenue. Historically, NKE stock has fallen 63% of the time after earnings announcements, with a median one-day decrease of 6.5% and a maximum decline of 20%. Also, see Buy or Sell Nike Stock?

Nike entered Q1 FY2026 with guidance indicating a mid-single-digit revenue reduction and a 350–425 bps impact on gross margin, which includes around 100 bps from new U.S. tariffs. Expenses are projected to rise slightly in the low single digits as the company invests in brand and wholesale initiatives. Tariffs, aging inventory, and subdued demand in China remain significant obstacles, while the success of the “Win Now” turnaround strategy will be crucial for Nike to halt its decline. Also, take a look at NuScale Stock: Big Gains, Bigger Risk

The company currently has a market capitalization of $102 billion. Over the last twelve months, revenue stood at $46 billion, and it recorded operational profitability with $3.7 billion in operating profits and a net income of $3.2 billion. Much will depend on how the results compare to consensus and expectations; however, grasping historical trends could provide an advantage if you are an event-driven trader.

For event-driven traders, historical trends can provide an advantage, whether by preparing ahead of earnings or responding to movements post-release. If you seek potential gains with lower volatility compared to individual stocks, the Trefis High Quality Portfolio serves as an alternative, having surpassed the S&P 500 and achieved returns exceeding 91% since its inception. See earnings reaction history of all stocks.

Historical Odds Of Positive Post-Earnings ReturnHere are some insights into one-day (1D) post-earnings returns:

MORE FOR YOU

Over the past five years, there have been 19 recorded earnings data points, with 7 positive and 12 negative one-day (1D) returns noted. Overall, positive 1D returns occurred approximately 37% of the time.This rate, however, declines to 25% when we look at data from the last 3 years instead of 5.Median of the 7 positive returns = 6.7%, and median of the 12 negative returns = -6.5%Additional information regarding 5-Day (5D) and 21-Day (21D) returns following earnings is compiled alongside the statistics in the table below.

NKE Correlation Between 1D, 5D, and 21D Forward Returns

Trefis

Correlation Between 1D, 5D, and 21D Historical ReturnsA comparatively lower-risk strategy (though it’s ineffective if the correlation is weak) involves understanding the relationship between short-term and medium-term returns after earnings, identifying a pairing with the strongest correlation, and executing the suitable trade. For instance, if 1D and 5D demonstrate the highest correlation, a trader may choose to position “long” for the subsequent 5 days if the 1D post-earnings return is positive. Below is some correlation information based on 5-year and 3-year (more recent) history. The correlation labeled 1D_5D refers to the connection between 1D post-earnings returns and later 5D returns.

NKE Correlation Between 1D, 5D, and 21D Historical Returns

Trefis

Discover more about the Trefis RV strategy that has surpassed its all-cap stocks benchmark (a combination of the S&P 500, S&P mid-cap, and Russell 2000), generating strong returns for investors.

CANADA - 2025/06/03: In this photo illustration, the MoonLake Immunotherapeutics (Moon Lake) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

SOPA Images/LightRocket via Getty Images

MoonLake Immunotherapeutics (NASDAQ: MLTX), a biopharmaceutical firm in the clinical stage, experienced substantial fluctuations last week. The stock climbed 10% on Friday, September 26, as investors expected favorable outcomes from Phase 3 trials of sonelokimab for hidradenitis suppurativa. However, this optimism turned out to be premature.

On Sunday, the company revealed outcomes from two pivotal trials, VELA-1 and VELA-2. While both studies technically met their primary and essential secondary endpoints using a pre-determined treatment policy method, the extent of the results differed significantly:

VELA-1: Sonelokimab exhibited a 17% greater response rate compared to placebo under composite analysisVELA-2: Only a 9% enhancement over placebo was recordedThe results from VELA-2 did not meet expectations, causing an approximate 90% drop in the stock during extended trading post-announcement. This sharp shift underscores the intrinsic volatility of clinical-stage biotech investments, where a single data release can dramatically transform valuations overnight. For investors looking for growth with less volatility than holding a single stock like Moonlake, consider the High Quality Portfolio. It has consistently outperformed its benchmark—a mix of the S&P 500, Russell, and S&P MidCap indexes—and has achieved returns of over 91% since its launch. What accounts for this? As a collective, HQ Portfolio stocks provided superior returns with reduced risk compared to the benchmark index; a smoother experience, as illustrated in HQ Portfolio performance metrics. In addition, see – IBM Stock Analysis: 2x Rise On Back of Strong Fundamentals But Valuations Stretched

Strategic Importance of SonelokimabSonelokimab is MoonLake’s most essential asset, with peak sales estimates surpassing $4 billion. Following the unsatisfactory VELA-2 results, analysts are likely to adjust their revenue forecasts and price targets downward. The current mean analyst price target of $76 will probably be revised to reflect the diminished commercial potential.

Financial Position AnalysisMoonLake’s financial profile displays both strengths and weaknesses:

MORE FOR YOU

Strengths:

A cash position of $425 million (92% of total assets)Manageable debt amounting to $76 millionA favorable debt-to-equity ratio below 2%Challenges:

No commercial products generating revenueOperating cash burn of $201 million in the past twelve monthsAbout two years of cash runway at the current burn rateWhile cash outflow is anticipated for clinical-stage companies, the combination of lower commercial expectations and ongoing high expenses creates financial strain.

Investment RisksThe stock comes with several risk factors:

Regulatory uncertainty: Weaker VELA-2 results may complicate discussions regarding FDA approvalValuation concerns: The stock was trading near historic highs before the announcement, suggesting limited upside and significant downside riskRevenue timeline: Years away from potential commercialization with no interim revenue streamsCash runway pressure: May necessitate additional financing within two years, possibly diluting current shareholdersSingle-asset dependency: The company’s valuation is heavily reliant on the success of sonelokimabClinical execution risk: Inconsistent trial outcomes raise concerns about drug efficacy and future study resultsCompetitive landscape: Other treatments in the pipeline could diminish market share forecastsThe Bottom LineConsidering the heightened risks and uncertain commercial prospects following the recent trial results, MoonLake is viewed as a speculative investment that may not be appropriate for most investors. The stock’s recent increase, alongside the disappointing VELA-2 data, indicates potential near-term downward pressure.

Instead of focusing capital in individual high-risk biotech stocks without thorough analysis, investors should consider diversified, professionally managed portfolios. Take a look at the Trefis Reinforced Value (RV) Portfolio, which has outperformed its all-cap stocks benchmark (a combination of the S&P 500, S&P mid-cap, and Russell 2000 benchmark indices) to deliver strong returns for investors. What accounts for this? The quarterly rebalanced mix of large-, mid-, and small-cap RV Portfolio stocks offers a responsive strategy to capitalize on favorable market conditions while mitigating losses when markets decline, as explained in RV Portfolio performance metrics.

Key Takeaways Lamar raised $400M from 5.375% Senior Notes due 2033 via private placement.The company secured a new $700M Term-Loan B, replacing debt due in 2027.Refinancing enhances liquidity and improves Lamar's debt maturity profile.
Lamar Advertising Company (LAMR - Free Report) announced that it has completed refinancing transactions totaling $1.1 billion via its wholly owned subsidiary, Lamar Media Corp. The move will aid the balance sheet strength required for future growth endeavors.

The transactions comprised the sale of 5.375% Senior Notes due 2033, amounting to $400 million through an institutional private placement. The sale proceeds are to be used for repayment of debt outstanding under the revolving portion of its senior credit facility and the Accounts Receivable Securitization Program.

Moreover, Lamar secured a new Term-Loan B (“TLB”) facility to the tune of $700 million. The seven-year TLB carries an interest rate of 150 basis points over SOFR. It serves as a replacement for the existing $600 million TLB, due 2027, and a part of the revolving portion of the senior credit facility.

LAMR: In a NutshellThis refinancing offers Lamar enhanced financial flexibility. The extended maturities of the assumed debt will help the company improve its maturity profile and enjoy greater liquidity for day-to-day operations.

LAMR makes efforts to boost its cash flow and alleviate bottom-line pressure. As of June 30, 2025, the company had $363 million of liquidity, consisting of $55.7 million of cash and cash equivalents and $307.3 million available under its revolving portion of senior credit facility.

In the past six months, shares of this Zacks Rank #3 (Hold) company have risen 6.9% against the industry's decline of 0.2%.

Image Source: Zacks Investment Research

Stocks to ConsiderSome better-ranked stocks from the REIT sector are Welltower (WELL - Free Report) and SL Green Realty (SLG - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for WELL’s 2025 FFO per share has been revised marginally upward over the past two months to $5.08.

The Zacks Consensus Estimate for SLG’s current-year FFO per share has been revised northward by 15.4% in the past three months to $6.21.

Note: Anything related to earnings presented in this write-up represents FFO — a widely used metric to gauge the performance of REITs.

The Zacks Computer-Peripheral Equipment industry players like Logitech (LOGI - Free Report) , Immersion (IMMR - Free Report) , Identiv (INVE - Free Report) and TransAct Technologies (TACT - Free Report) are well-poised to benefit from the growing demand for professional gaming accessories, touchscreen and wireless devices, smart glasses and RFID (Radio Frequency Identification) solutions. A continuously improving shipment of personal computers (PCs) bodes well for PC peripheral market prospects. Moreover, the solid demand for 3D-printed health equipment like face shields, nasal swabs and ventilator parts has been a tailwind.

However, the industry has been suffering from macroeconomic headwinds, including inflationary pressures and high interest rates. These have induced sluggishness in IT spending, affecting the demand for computer peripherals. Moreover, the near-term prospects of the PC industry seem highly volatile, given an uncertain environment triggered by the U.S. government’s new tariff policies.

Industry Description
The Zacks Computer-Peripheral Equipment industry comprises companies offering computer input, output and storage devices. These include keyboards, mice, LCD panels, smart glass, analog-to-digital imaging solutions, touch sensors, 3D printers & additive manufacturing and transaction-based printer products, among others. Moreover, video gaming accessories, including gaming mice, wired gaming headsets, in-ear gaming headphones and controllers for Xbox One and PlayStation, are offered by these companies. The highly competitive nature of the industry is encouraging participants to develop innovative and relevant products that meet the current demand trend. This is strengthening their product portfolios.

Trends Shaping the Future of the Computer-Peripheral Equipment Industry
Shift in Consumer Preference - A Key Catalyst: The gradual shift in consumer preference from mobile gaming to a more professional gaming experience is a major growth driver. The launch of advanced gaming devices and the rising popularity of e-sports leagues are expected to boost prospects. Markedly, e-sports is also likely to continue aiding the total addressable market in the gaming peripherals industry. In addition, the 3D printing market presents a favorable long-term investment opportunity as a large number of engineers, designers, architects and entrepreneurs are resorting to 3D solutions for primary designing and product modeling. Additionally, the increasing adoption of advanced 3D technologies across various industries, including medical, aerospace, and automotive, is a significant driving force for this industry.

Expanding Global Footprint: The expansion of the total addressable market bodes well for the industry participants. Deepening penetration into price-sensitive regions, such as the Asia Pacific and the Middle East & Africa, through low-cost, high-quality products boosts growth prospects.

Improving Commercial PC Demand to Boost Prospects: An increase in commercial PC demand is likely to benefit the computer peripherals industry’s prospects in the near term. Rising interest in PCs equipped with on-device AI capabilities is likely to drive demand for commercial PCs. The beginning of the PC refreshment cycle and Windows 11 upgrades are likely to remain key catalysts for PC market growth in the quarters ahead. This will provide further growth momentum to the computer peripherals equipment industry, as PCs are the primary drivers of sales for companies in this space.

Macroeconomic Headwinds May Impact IT Spending: High interest rates and prolonged inflationary conditions are affecting consumer spending. On the other hand, enterprises are postponing their large IT spending plans due to a weakening global economy amid ongoing macroeconomic and geopolitical issues. The U.S. government’s new tariff policies on imports could raise costs for both suppliers and end-users in the coming months. This does not bode well for the prospects of the Computer-Peripheral Equipment market in the near term.

Elevated Operating Expenses to Hurt Profitability: To survive in the highly competitive computer peripheral market, each player is aggressively investing in research and development to enhance their product portfolio and broaden their capabilities. Moreover, companies are seeking to enhance their sales and marketing capabilities, particularly by expanding their sales force. Elevated operating expenses, aimed at capturing more market share, are likely to dent margins in the near term.

Zacks Industry Rank Indicates Bright Prospects
The Zacks Computer-Peripheral Equipment industry is housed within the broader Zacks Computer and Technology sector. It carries a Zacks Industry Rank #30, which places it in the top 12% of approximately 250 Zacks industries.

The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates robust near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.

The industry’s position in the top 50% of the Zacks-ranked industries is a result of the positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are optimistic about this group’s earnings growth potential.

Given the bright industry outlook, several stocks are worth watching. However, before we present the stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock market performance and valuation.

Industry Outperforms S&P 500 But Lags Sector
The Zacks Computer-Peripheral Equipment industry has underperformed the S&P 500 composite and the broader Zacks Computer and Technology sector in the trailing 12 months.

The industry has soared 20.4% during this period. The S&P 500 and the broader sector have risen 17.2% and 28.3%, respectively, over the same time frame.

One-Year Price Performance

Industry's Current Valuation
Based on the forward 12-month P/S, which is a commonly used multiple for valuing computer peripheral stocks, we see that the industry is currently trading at 0.90X compared with the S&P 500’s 5.40X and the Zacks Computer and Technology sector’s 7.01X.

Over the last five years, the industry has traded as high as 4.81X, as low as 0.20X and at the median of 0.74X, as the chart below shows.

Trailing 12-Month P/S Ratio (Industry vs. S&P 500)

Trailing 12-Month P/S Ratio (Industry vs. Sector)

4 Stocks in Focus
TransAct Technologies: The company designs, develops, manufactures and markets transaction-based printers and related products under the BOHA, AccuDate, Epic and Ithaca brand names. This Zacks Rank #2 (Buy) company focuses on five vertical markets — point-of-sale, gaming and lottery, financial services, kiosks and the Internet. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

TransAct Technologies is benefiting from the growing demand for its products and services amid accelerated digital transformation and business automation across organizations. The company's printers are trusted worldwide to provide crisp, clean transaction records from receipts, tickets and coupons, register journals and other documents.

The Zacks Consensus Estimate for the 2025 bottom line is pegged at a loss of 15 cents per share, narrower than the loss of 19 cents projected 60 days ago. The stock has risen 9.1% over the past year.

Price and Consensus: TACT

Identiv offers RFID, Internet of Things (IoT) devices and IoT software platforms. Its growing dominance in the RFID-enabled IoT business benefits top-line growth. The company is also benefiting from securing successful design agreements. Its technical proficiency in intellectual property, expertise in the RFID segment and ongoing deal wins position it well in the IoT market.

The Zacks Consensus Estimate for this Zacks Rank #2 company’s 2025 loss is pegged at 95 cents per share, narrower than the loss of $1.13 projected 60 days ago. Its shares have gained 3.1% over the past year.

Price and Consensus: INVE

Immersion: The company is a trailblazer in the flourishing haptic technology space, which provides tactile feedback for several industries, such as gaming, automotive and virtual reality (VR). The demand for haptic technology is growing, and IMMR’s strong intellectual property portfolio — backed by several patents — positions it well to capitalize on this growth.

Immersion’s technology is already integrated into more than three billion devices globally. Its impressive client base includes more than 150 licensed customers. This Zacks Rank #3 (Hold) company’s strong market presence solidifies its position as a key player in the haptic space.

IMMR’s partnerships are a major factor driving its market success. Licensing agreements with Sony Group, Samsung and Meta Platforms extend Immersion’s reach into VR, gaming and mobile markets.

The Zacks Consensus Estimate for fiscal 2026 earnings has remained unchanged at 42 cents per share over the past 60 days. IMMR stock has declined 19.9% in the past 12 months.

Price and Consensus: IMMR

Logitech: It is a global leader in peripherals for personal computers and other digital platforms. The company develops and markets innovative products in PC navigation, Internet communications, digital music, home entertainment control, video security, interactive gaming and wireless devices.

Logitech’s back-to-back strong quarterly results have boosted investors’ confidence in its recovery from the post-pandemic downturn. The latest reported results for the first quarter of fiscal 2026 marked the sixth consecutive quarter of year-over-year sales growth after two and a half years of downturn post the pandemic-driven boom.

Increasing hybrid work trends are likely to boost demand for its video collaboration, keyboards & combos and pointing device tools. Thriving cloud-based video conferencing services continue to be its key catalyst. The rising adoption of new mobile platforms in both mature and emerging markets should fuel the demand for its peripherals and accessories. Its partnerships with cloud providers like Zoom Video and Microsoft are major upsides.

The Zacks Consensus Estimate for fiscal 2026 earnings has been revised upward by a penny to $5.04 per share over the past seven days. Shares of this Zacks Rank #3 company have soared 20.7% over the past year.

Price and Consensus: LOGI

Key Takeaways Globalstar launched XCOM RAN, claiming at least 4x higher capacity than baseline 5G NR systems.The firm completed its first 5G data call using XCOM RAN over n53 spectrum with 100/60 Mbps speeds.Heavy XCOM RAN investment cut Q2 EBITDA by $1.9M, though 2025 revenue is guided at $260-$285M.
Globalstar, Inc. (GSAT - Free Report) , known for its satellite communications services, is making a strategic bet on XCOM’s Radio Access Network (RAN) technology as another key growth driver in its evolving portfolio. In February 2024, Globalstar announced the commercial availability of its XCOM RAN multipoint RAN for private wireless deployments, highlighting that it could deliver at least 4 times higher capacity compared to baseline 5G NR systems.

In December 2024, Globalstar achieved its first 5G data call using XCOM RAN over its n53 spectrum, reaching speeds of 100 Mbps downlink and 60 Mbps uplink. This experiment used prototype radios and 5G modules, and demonstrated that the combination of XCOM’s radio technology with licensed mid-band spectrum can support demanding, mission-critical applications. In August 2025, the company revealed that its XCOM RAN architecture would be used to evaluate high-capacity 5G systems tailored for defense and tactical environments.

Globalstar continues to advance the software-defined, end-to-end XCOM RAN solution, supported by strong technical validation and growing interest from prospective partners. Offering lower latency, greater spectral efficiency, easier deployment and dynamic spectrum sharing, XCOM RAN has the potential to significantly broaden Globalstar’s addressable market while enabling future hybrid satellite-terrestrial architectures.

In the second quarter, Globalstar invested heavily in the continued development and enhancement of XCOM RAN. These efforts, while increasing cash costs and pressuring adjusted EBITDA by approximately $1.9 million, also reduced the adjusted EBITDA margin by 300 basis points compared to the prior year. However, the company had anticipated these upfront costs and remains confident in the long-term profitability and strategic significance of the product.

For 2025, the company anticipates revenues to be in the range of $260-$285 million and expects adjusted EBITDA margins around 50%. 
However, the satellite and communications sector face intense competition, driven by rapid technological innovation and an increasing wave of new players entering the market alongside established providers. Players like Iridium Communications (IRDM - Free Report) and Gilat Satellite Networks (GILT - Free Report) are eyeing significant expansion of their addressable markets amid the increasing demand for global connectivity.

Taking a Look at IRDM & GILT Growth DriversIridium STL, powered by Satelles, offers a stronger and more reliable timing and location service, available globally at low cost. Interest in this solution has grown significantly, and it’s expected to be a key growth driver through 2030 across civil and commercial markets. Iridium plans to build its next-generation network in the 2030s, delivering standards-based 5G/6G services directly to consumer devices for enhanced connectivity beyond cell towers. The network will also host Aireon and introduce space-based VHF services, supporting the aviation industry’s shift from ground-based to satellite communications. Also, the company aims to strengthen and expand its role as the global alternative for PNT across critical infrastructure, leveraging its spectrum assets, partner ecosystem and proven strategy to sustain long-term leadership.

Key catalysts over the next five years include TNT, NTN Direct and IoT, while by 2030, D2D, PNT, IoT and government are expected to push service revenues to Iridium’s $1 billion target. However, the company has cut its 2025 service revenue growth view to 3-5% (from 5-7%), citing the maritime broadband transition, USAID-related voice losses and a PNT revenue delay to 2026.

GILT offers advanced solutions across sectors like In-Flight Connectivity (IFC), defense and public safety. With rising global demand for defense SATCOM, driven by NGSO growth and geopolitical tensions, Gilat is well-positioned to capitalize on these trends through its deep expertise and continued investment in secure, high-performance satellite communication technologies. In August 2025, Gilat announced that its defense division, Gilat Defense, secured a multimillion-dollar contract from Israel’s Ministry of Defense. In the second quarter of 2025, Gilat’s Defense division strengthened its growth foundation amid rising global defense spending and demand for secure SATCOM solutions. In addition, Gilat DataPath secured a contract to provide field and technical services for the U.S. Army, starting with an initial order of more than $7 million.

For 2025, the company anticipates revenues to be in the range of $435 million to $455 million, up from the previous forecast of $415 million to $455 million. Adjusted EBITDA is anticipated between $50 million and $53 million compared with the earlier range of $47 million to $53 million.

GSAT’s Price Performance, Valuation and EstimatesGSAT’s shares have gained 83.9% in the past year compared with the Zacks Satellite and Communication industry's growth of 129.5%.

Image Source: Zacks Investment Research

GSAT stock is trading at a substantial premium, with a forward 12-month price/sales of 14.32X compared with the industry’s 1.37X.

Image Source: Zacks Investment Research

GSAT’s estimates are on an upward trajectory at present. The consensus mark for 2025 earnings has been revised up 77.1% to a loss of 8 cents per share over the past 60 days and the same for 2026 has moved north 200% to 1 cent.

Image Source: Zacks Investment Research

At present, GSAT sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shawn Matthews, CEO of DNA Holdings and Former CEO of Cantor Fitzgerald, will join the Board of Directors upon the closing of the private placements

Predictive Oncology continues to execute on its artificial intelligence and machine learning business to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide  

PITTSBURGH, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (“Predictive Oncology” or the “Company”) (Nasdaq: POAI) today announced the pricing of two private placement transactions to support its adoption of a digital asset treasury strategy under which the principal holding will be ATH, the native utility token of the Aethir ecosystem.

Transaction Overview

The Company to raise an aggregate of approximately $344.4 million in two private investment in public equity transactions (“PIPEs”) for the purchase and sale of (i) an aggregate of approximately 66.7 million shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) for a purchase price of $0.7751 per share (the “Offering Price”) of common stock (or per pre-funded warrant in lieu thereof) for aggregate cash gross proceeds of approximately $51.7 million (the “Cash PIPE”), and (ii) pre-funded warrants to purchase up to 223.6 million shares of common stock for a purchase price equal to the Offering Price minus $0.01 per pre-funded warrant in exchange for approximately $292.7 million in notional value representing $173.3 million in discounted value, of in-kind contributions of locked and unlocked Aethir tokens (the “Crypto PIPE”). The pre-funded warrants to be issued in the Crypto PIPE will become exercisable immediately following the Company’s receipt of shareholder approval for the exercise of such pre-funded warrants. The PIPEs are expected to close concurrently on or about October 2, 2025, subject to the satisfaction of customary closing conditions.

The Company intends to use the in-kind contribution of ATH to fund the Company’s digital asset treasury strategy and to use the remaining net proceeds from the PIPEs primarily to fund the acquisition of ATH in the open market in further support thereof, as well as for working capital and general corporate purposes.

DNA Holdings Venture, Inc. will serve as the Company’s strategic advisor and consultant for the Company’s digital asset treasury.

Aethir operates one of the world’s largest decentralized GPU networks, offering enterprise-grade AI infrastructure with approximately 40–80% cost savings compared to traditional and neocloud providers. The network spans 435,000 GPU containers across 200+ locations in 93 countries, enabling global access to Nvidia GPUs-as-a-Service. This infrastructure powers researchers, start-ups, and enterprises with rapid deployment (24–48 hours instead of months), ensuring they can scale AI workloads quickly and efficiently.

To expand this reach, the Company’s digital asset treasury will manage ATH tokens, leveraging Aethir’s flywheel model by facilitating rapid deployment and monetization of compute resources across Web2 and Web3 enterprise verticals. ATH tokens provide the utility, rewards, and access to high-end GPU compute resources. Compute providers stake ATH as collateral, ensuring service level adherence and enabling rapid deployment.

For each ATH token purchased by the Company on the open market, whether through a centralized exchange or a decentralized exchange operating on the Ethereum Network, the DCI Foundation will grant to the Company an additional 20% of the number of ATH tokens so purchased. This utility-driven model directly links ATH token value to real-world infrastructure demand, democratizing access to AI infrastructure.

“Our partnership with Aethir represents a seminal event for Predictive Oncology and we believe it creates an outstanding opportunity for the Company and our shareholders to solidify and expand our core business while embarking upon an incremental growth opportunity through our digital asset treasury strategy,” commented Raymond Vennare, Chief Executive Officer and Chairman of the Board of Predictive Oncology.

“With the planned adoption of the Company’s digital asset strategy, we will be able to establish the world’s first Strategic Compute Reserve. The Company will act not just as a digital asset treasury, but through its planned holdings of ATH, it will be able to function as an operator on the Aethir ecosystem that we believe will strengthen Aethir’s ability to provide the global infrastructure layer for the future of AI,” said Dan Wang, Co-Founder and CEO of Aethir.

Advisors     

DNA Holdings Venture Inc. is acting as the strategic advisor and an investor in the Cash PIPE.

H.C. Wainwright & Co. is acting as the exclusive placement agent in connection with the PIPEs.

DLA Piper LLP (US) is serving as counsel to the Company.

Shepphard, Mullin, Richter & Hampton LLP, is serving as counsel to DNA Holdings Venture, Inc., the Company’s strategic advisor.

Disclaimer

The offer and sale of the foregoing securities in the PIPEs were made in a private placement in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, and applicable state securities laws. Accordingly, the securities offered in the PIPEs may not be re-offered or re-sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. Concurrently with the execution of the securities purchase agreements for the PIPEs, the Company and the investors entered into a registration rights agreement pursuant to which the Company agreed to file one or more registration statements with the Securities and Exchange Commission registering the resale of the securities to be issued or issuable in connection with the PIPEs.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

The information provided in this press release is intended for informational purposes only and does not constitute investment advice, endorsement, analysis, or recommendations with respect to any financial instruments, investments, or issuers. Investment in cryptocurrency and DeFi projects involves substantial risk, including the risk of complete loss. This press release does not take into account the investment objectives, financial situation, or specific needs of any particular person and each individual is urged to consult their legal and financial advisors before making any investment decisions.

On September 19, 2025, the Company’s stockholders approved a one-for-fifteen (1-for-15) reverse stock split of the Company’s common stock which will become effective at 12:01 a.m. on Tuesday, September 30, 2025. All share and price per share information included in this press release is presented on a pre-split basis and the exercise price of $0.01 for the pre-funded warrants will not be adjusted upon the reverse stock split.

About Predictive Oncology

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly owned CLIA laboratory facility. Predictive Oncology is headquartered in Pittsburgh, PA.

The Company will initiate a digital asset treasury strategy focused on accumulating ATH, the native utility token of the Aethir ecosystem.

About Aethir

Aethir is a leading AI decentralized physical infrastructure network (“DePIN”) developed by DCI Foundation, a Panama foundation company which provides graphics processing units (“GPUs”) as-a-Service at enterprise scale for applications including artificial intelligence computation, gaming and cloud workloads. Aethir’s mission is to democratize access to AI infrastructure through its globally distributed network. Due in part to the decentralized nature of the Aethir network, Aethir can facilitate the provision of GPU compute power at a significant discount to established centralized GPU compute providers, such as AWS and Google Cloud. ATH is a utility token used for GPU rentals, staking, validation and the provision of ecosystem rewards on the Aethir network. ATH functions as a proxy for a unit of GPU compute power, and serves as a medium of exchange and unit of incentives for participants in the Aethir network. Participants in the Aethir network can generate yield or other rewards by staking or lending ATH or by otherwise serving as a source of ATH liquidity.

Forward Looking Statements

This press release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. This press release also includes express and implied forward-looking statements regarding the Company’s current expectations, estimates, opinions and beliefs that are not historical facts. Such forward-looking statements may be identified by words such as “believes,” “expects,” “endeavors,” “anticipates,” “intends,” “plans,” “estimates,” “projects,” “should” and “objective” and the negative and variations of such words and similar words. These statements are made on the basis of current knowledge and, by their nature, involve numerous assumptions and uncertainties. Nothing set forth herein should be regarded as a representation, warranty or prediction that we will achieve or are likely to achieve any particular future result. Actual results may differ materially from those indicated in the forward-looking statements because the realization of those results is subject to many risks and uncertainties, including the risk that the proposed private placements and the transactions described herein may not be completed in a timely manner or at all, the failure to realize the anticipated benefits of the private placement and related transactions, including the Company’s proposed digital asset treasury strategy, economic conditions, fluctuations in the market price of ATH and other digital assets, the impact on the Company’s business of the evolving regulatory environment, the ability of the Company to execute on its digital asset treasury strategy and implications for shareholders and for the Company’s core business, the ability of the Aethir ecosystem to perform in a manner consistent with projections, receipt of shareholder approval for the exercise of the pre-funded warrants issued in connection with the Crypto PIPE and related matters, market and other conditions, as well as other factors. Forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertake no duty to update such information except as required under applicable law.

Investor Relations Contact:
Michael Moyer
LifeSci Advisors, LLC
[email protected]

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CAPR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Bitcoin (BTC) is expected to experience significant corrections before it can reach new all-time highs, according to market analyst Jordi Visser. Despite the typical strength seen in the fourth quarter for crypto assets, Visser predicts BTC will face price drops of 20% or more as it continues its upward trajectory.

Story IP has made a comeback after a turbulent week, catching the attention of crypto traders everywhere. The token surged 11.8% overnight to $9.62, recovering losses from its steep 29% decline from the September 22 all-time high of $14.89. Its market cap now stands at $3.01 billion, with daily trading volume soaring by over 42% to $235.5 million. It is worth noting that both retail activity and ecosystem news are shaping this sudden turnaround.

Why is IP Price Up Today?The main driver behind the rebound is retail trading. Many smaller investors jumped on the dip, pushing volumes higher. As per CryptoQuant, retail traders now dominate activity, with a slightly bullish tilt reflected in the Long/Short ratio of 1.03. 

On the development side, Story IP has been boosted by its Origin Summit partnership with Verse8. The deal introduces Moonbirds and Azuki IP into AI-powered gaming experiences. While the direct revenue impact is still modest, the news has sparked excitement across social platforms and revived interest in the token.

That weakness is clear when looking at numbers: protocol revenue is only $679 a day, far below what you’d expect for a project valued at $3 billion. This imbalance highlights just how speculative current trading is, meaning volatility is likely to stay high.

Story IP Price AnalysisLooking at things from a technical lens, the token has reclaimed its 30-day SMA at $9.62. This signals some potential for more gains if momentum continues. A bullish divergence in the RSI also suggests the token was oversold and is now bouncing back. However, still, bearish signs remain, as the MACD is in negative territory at -0.445, and the 7-day RSI sits at a muted 42.7.

Key levels to watch are $9.37 on the downside and $10.42 on the upside. If Story IP price holds above $9.37 and breaks through $10.20, the door could open for further upside. But if it slips below support, the next stop may be $7.86.

FAQsWhat caused Story IP’s latest price rally?

Retail traders bought the dip after a 51% drop from its all-time high, sending volume higher and lifting the price.

Can this rebound last?

It depends on whether whales and institutions step in. Without them, volatility will remain high.

How do partnerships affect price?

Ecosystem news, like the Verse8 gaming collaboration, boosts sentiment and retail buzz, even if revenue impact is still limited.

NewsPricesDataIndicesResearchEventsSponsoredSign InSign UpYour day-ahead look for Sept. 29, 2025 Sep 29, 2025, 11:15 a.m.

October tends to be bitcoin's best month of the year. (Midjourney/Modified by CoinDesk)

What to know: You are viewing Crypto Daybook Americas, your morning briefing on what happened in the crypto markets overnight and what's expected during the coming day. Crypto Daybook Americas will arrive in your inbox at 7 a.m. ET to kickstart your morning with comprehensive insights. If you're not already subscribed, click here. You won't want to start your day without it.

By James Van Straten (All times ET unless indicated otherwise)

BTC$112,098.82, up 2.5% in the past 24 hours, has created a CME futures gap between $110,000 and $111,335. That's the difference between its prices when the CME market closed for the week on Friday and reopened on Sunday.

STORY CONTINUES BELOW

ETH$4,107.86 is showing a similar setup. That has gained 3.4% and left a futures gap starting around $4,000.

The thing about CME futures gaps is that they tend to get filled. With the two largest cryptocurrencies currently trading higher, that means they both — at some point — are likely to drop back and retest those lower levels.

Bitcoin’s monthly low often tends to occur within the first 10 trading days, meaning this dip could arrive within the next two weeks. That's even though October, often referred to as “Uptober,” is historically its second-best performing month with an average return of 22%.

More broadly, the CoinDesk 20 Index has gained 3.2% in the past 24 hours with all members in the green.

Outside of crypto, precious metals remain firm, with gold climbing 1.5% on Monday to $3,815 and silver approaching all time highs at $47, with the next breakout level at $50.

Macro markets are focused on Friday’s highly influential U.S. jobs report, with nonfarm payrolls, a measure of new jobs excluding farm work and certain categories, expected at 39,000 alongside a steady 4.3% unemployment rate. ISM Services PMI is forecast at 52, indicating continued expansion of the world's largest economy.

For bitcoin to break out of its current $110,000 to $120,000 trading range, volatility and sentiment will need to return. The fourth quarter, which starts on Wednesday, could provide the catalyst. Stay alert!

What to WatchCryptoSept. 29, 8:00 p.m.: PancakeSwap (CAKE) discontinues support for Polygon zkEVM liquidity pools and Perpetual V1 orderbook. Users must withdraw funds by the deadline.MacroSept. 29, 7:30 a.m.: Fed Governor Christopher J. Waller gives a speech on "Payments" in Frankfurt.Sept. 29, 10:30 a.m.: Sept. Dallas Fed Manufacturing Index (Prev. -1.8)Sept. 29, 1 p.m.: U.S. agencies SEC and CFTC hold a roundtable on regulatory harmonization efforts. Watch live.Earnings (Estimates based on FactSet data)Nothing scheduled.Token EventsGovernance votes & callsLido DAO is voting on the design and implementation of its Lido V3 upgrade, which among other things introduces staking vaults (stVaults) that allow users to select specific staking operators. Voting ends Sept. 29.UnlocksNothing scheduled.Token LaunchesSept. 29: Anoma (XAN) to be listed on KuCoin.Sept. 29: Ronin (RON) treasury buybacks begin.Sept. 29: Falcon Finance (FF) to be listed on Binance, BingX, KuCoin, Gate.io, Bitget and others.ConferencesSept. 29: CoinFerenceX SingaporeDay 1 of 2: Sonic Summit 2025 (Singapore)Token TalkBy Oliver Knight

Plasma’s native token, XPL, is beginning to cool off following its red-hot trading debut. The Tether-backed token is changing hands at $1.29, down 12% over the past 24 hours, as daily trading volume slipped 9% to $2.3 billion.On-chain activity, however, tells a different story, with deposits rising 13.7% to $5.5 billion in the same period. Much of that capital is flowing into yield-generating products like Plasma Saving Vaults, which currently offer around 20% annualized returns on lending vaults.The combination of attractive yields and rapid inflows has helped Plasma quickly climb the blockchain rankings, already overtaking Coinbase-backed Base in terms of total value locked, according to data from DeFiLlama.While trading activity for XPL has cooled, inflows suggest strong investor appetite during a relative lull in the wider crypto markets as assets like BTC and ETH fell back to respective levels of support at the tail end of last week.It remains to be seen how well Plasma and its protocols fare during a bullish market phase, but the stablecoin-focused blockchain has already earned its fruits when the market is under pressure.Derivatives PositioningOverall BTC futures open interest has dropped to roughly $29 billion from a recent high of $32 billion, indicating that traders are reducing their exposure. At the same time, the three-month annualized basis remains compressed at around 6%, making the basis trade less profitable. In essence, the market is showing a clear shift from a bullish bias as traders unwind their long positions and a growing number of shorts enter the market.In options, the BTC Implied Volatility Term Structure shows an upward-sloping curve while the 25 delta skew for short-term options (1-week, 1-month) has increased, suggesting that some traders are paying a premium for calls over puts, indicating a bullish bias.This is directly contradicted by the 24-hour put-call volume, which shows puts dominating with 58.43% of contracts traded, a sign that a large number of traders are still seeking downside protection. The divergence suggests a highly polarized market where some are betting on a short-term rally while others are actively hedging against further declines, leading to a state of indecision and mixed sentiment.BTC funding rates have recently turned negative, suggesting a growing bearish sentiment. After holding steady for most of the week, the annualized funding rate on Hyperliquid dropped significantly to a negative -6%. This indicates a strong conviction from traders who are shorting BTC on that platform. Meanwhile, funding rates on major venues like Binance and OKX remain near neutral. The overall trend, particularly the sharp drop on Hyperliquid, suggests that traders are actively taking risk off the table and positioning for a decline in BTC prices.Coinglass data shows $350 million in 24 hour liquidations, with a 24-76 split between longs and shorts. ETH ($130 million), BTC ($52 million) and SOL ($37 million) were the leaders in terms of notional liquidations. Binance's liquidation heatmap indicates $113,000 as a core liquidation level to monitor, in case of a price rise.Market MovementsBTC is up 2.54% from 4 p.m. ET Friday at $112,164.29 (24hrs: +2.49%)ETH is up 3.1% at $4,136.88 (24hrs: +3.38%)CoinDesk 20 is up 2.76% at 3,985.34 (24hrs: +3.2%)Ether CESR Composite Staking Rate is down 9 bps at 2.81%BTC funding rate is at -0.0012% (-1.2855% annualized) on BinanceDXY is down 0.19% at 97.96Gold futures are up 0.76% at $3,838.10Silver futures are up 0.73% at $46.99Nikkei 225 closed down 0.69% at 45,043.75Hang Seng closed up 1.89% at 26,622.88FTSE is up 0.58% at 9,338.77Euro Stoxx 50 is up 0.14% at 5,507.35DJIA closed on Friday up 0.65% at 46,247.29S&P 500 closed up 0.59% at 6,643.70Nasdaq Composite closed up 0.44% at 22,484.07S&P/TSX Composite closed up 0.1% at 29,761.28S&P 40 Latin America closed up 0.43% at 2,920.80U.S. 10-Year Treasury rate is down 4.4 bps at 4.143%E-mini S&P 500 futures are up 0.51% at 6,730.75E-mini Nasdaq-100 futures are up 0.64% at 24,885.75E-mini Dow Jones Industrial Average Index are up 0.4% at 46,741.00Bitcoin StatsBTC Dominance: 58.61% (0.11%)Ether to bitcoin ratio: 0.03687 (-0.16%)Hashrate (seven-day moving average): 1,051 EH/sHashprice (spot): $49.78Total Fees: 2.19 BTC / $241,364CME Futures Open Interest: 134,900 BTCBTC priced in gold: 29.6 ozBTC vs gold market cap: 8.35%Technical AnalysisEther has rebounded from the 100-day exponential moving average, reclaiming ground above the key psychological level of $4,000. While this recovery signals resilience, the short-term trend remains tilted to the downside, with the 50-day EMA — currently near $4,210 — acting as immediate resistance. For bullish momentum to build, traders will be watching closely to see if ETH can continue to respect weekly support and establish acceptance above the recent weekly swing low.
Crypto EquitiesCoinbase Global (COIN): closed on Friday at $312.59 (+1.92%), +2.26% at $319.66 in pre-marketCircle Internet (CRCL): closed at $126.99 (+1.87%), +1.98% at $129.50Galaxy Digital (GLXY): closed at $30.90 (-3.78%), +3.27% at $31.91Bullish (BLSH): closed at $62.59 (+1.23%), +1.9% at $63.78MARA Holdings (MARA): closed at $16.13 (+0.37%), +2.67% at $16.56Riot Platforms (RIOT): closed at $17.69 (+5.68%), +3% at $18.22Core Scientific (CORZ): closed at $16.85 (+0.06%), +2.08% at $17.20CleanSpark (CLSK): closed at $12.96 (-5.26%), +3.16% at $13.37CoinShares Valkyrie Bitcoin Miners ETF (WGMI): closed at $40.61 (-3.68%)Exodus Movement (EXOD): closed at $28.51 (-1.35%), +2.81% at $29.31Crypto Treasury Companies

Strategy (MSTR): closed at $309.06 (+2.78%), +2.3% at $316.17Semler Scientific (SMLR): closed at $28.31 (-6.29%), +2.3% at $28.96SharpLink Gaming (SBET): closed at $16 (-1.9%), +1.94% at $16.3 1Upexi (UPXI): closed at $5.22 (-1.23%), +1.63% at $5.30Lite Strategy (LITS): closed at $2.56 (+0.79%), +4.3% at $2.67 ETF FlowsSpot BTC ETFs

Daily net flows: -$418.3 millionCumulative net flows: $56.78 billionTotal BTC holdings ~1.32 millionSpot ETH ETFs

Daily net flows: -$248.4 millionCumulative net flows: $13.14 billionTotal ETH holdings ~6.52 millionSource: Farside Investors

While You Were SleepingSwift to Build a Blockchain-Based Ledger for Financial Firms (Bloomberg): The first prototype, developed in collaboration with more than 30 banks, will use Joe Lubin-led Consensys' technology for real-time cross-border payments.Revolut Weighs $75B Dual Listing in New York and London (Sunday Times): The move could be a vote of confidence for London's financial center and would make fintech the first company to simultaneously list in New York and enter the FTSE 100.Economists Favour Christopher Waller to Lead Fed but Expect Trump to Pick a Loyalist (Financial Times): Economists surveyed by the FT expect Kevin Hassett, chair of the White House’s National Economic Council, to prevail, citing Trump’s focus on loyalty and aggressive rate cuts.Maple Finance to Tie Into Elwood to Bring Institutional Credit Strategies On-Chain (CoinDesk): The integration is meant to give banks and asset managers smoother entry into digital credit markets by pairing on-chain lending strategies with institutional trading and risk systems.Fear and Hope in Venezuela as U.S. Warships Lurk (The New York Times): As U.S. warships circle and threats intensify, Venezuelans remain split between calls for foreign-backed regime change, fear of chaos after Maduro and weary resignation that little will change.More For You

Trump Tariffs, GDP Rattle Markets, ETFs Bleed: Crypto Daybook Americas

Sep 26, 2025

Your day-ahead look for Sept. 26, 2025

What to know:

You are viewing Crypto Daybook Americas, your morning briefing on what happened in the crypto markets overnight and what's expected during the coming day. Crypto Daybook Americas will arrive in your inbox at 7 a.m. ET to kickstart your morning with comprehensive insights. If you're not already subscribed, click here. You won't want to start your day without it.

Read full story

Top Stories

Short-term BTC buyers are feeling selling pressure, potentially leading to a capitulation. Events like that can cause short-term volatility, eventually setting up the market for new accumulation. 

BTC short-term holders felt the pinch of the current downturn. The latest cohorts of buyers are not necessarily panic-selling, but their pressure point is above $111,000. The recent dip of BTC to $109,000 set up conditions for a minor capitulation. 

Based on Glassnode data, the Net Unrealized Profit/Loss (NUPL) index for short-term buyers has shifted to a small loss, suggesting some traders may decide to sell and eventually buy lower. 

In the past months, steep drops in the NUPL metric coincided with a market local bottom, usually preceding a recovery following the redistribution of coins. BTC continues to go through a cycle with 25% drawdowns and fewer capitulation events on the spot market. 

The crypto fear and greed index is at 50 points and is neutral after a few days of fearful trading. However, the index shows the attitude of derivative traders, while holders show more resilience. 

Are BTC holders ready to capitulate? 
Despite the NUPL metric turning worse for the latest buyers, in general, BTC holders are very far from capitulation. As Cryptopolitan previously reported, the current market cycle has spent more than a year without a big capitulation event, only with short-term liquidations and deleveraging.

Short-term BTC buyers may be underwater, but on average, holders are not feeling anxiety and are in the money. | Source: Bitcoin Magazine Pro
At current valuations, on average, holders are not even in the anxiety zone, boosted by previous accumulation in the past year. BTC gains support from an ongoing push to hold more coins, avoiding capitulation. 

Market downturns usually lead to large-scale position liquidations, but BTC owners are not eager to sell, expecting more value from BTC as a reserve. 

Based on HODL waves data, wallets aged over one month have only expanded their reserves. Shark wallets went through rapid accumulation, with no signs of preparing to sell. In the past year, shark wallets added more than 1M BTC, accumulating even during periods of market panic.

Direct dumping on the market is now rarer, as DeFi offers additional opportunities to tap the value without crashing the BTC price. 

Will BTC miners capitulate? 
BTC miners have always faced the threat of capitulation. At the current market price, most miners are profitable. Based on the hash ribbon metrics, miners are currently not producing coins at a loss and are not in distress. 

Miner sell pressure diminished in the past year and is near all-time lows, despite the highly competitive mining sector. | Source: BGeometrics
Miners, just like long-term holders, are now more cautious when divesting BTC. Miners retain reserves of 1.89M BTC, close to their usual level. Miner sell pressure has actually fallen since the end of 2024, and is close to all-time lows. 

While miners sell strategically, mass inflows to open markets are much rarer. Newly mined coins are also valuable as they lack a history of involvement with illegal activities. 

With the rise of treasuries, miners also have another motive to store their BTC, especially for publicly traded mining companies. 

Your crypto news deserves attention - KEY Difference Wire puts you on 250+ top sites

Key NotesHumidiFi has become the top decentralized exchange on Solana by trading volume on the weekly timeframe, surpassing Meteora.
HumidiFi has recently climbed to the top of Solana’s decentralized exchange rankings, recording $8.55 billion in trading volume over the past week. The dark-pool protocol, which uses proprietary automated market makers (prop AMMs), outpaced rivals Meteora, Raydium, and PumpSwap.

According to data from DeFiLlama, on Sept. 25 alone, HumidiFi processed a record $1.92 billion in trades, more than one-third of Solana’s total daily volume. Currently, it records a 24-hour trading volume of $557 million, second only to Meteora’s $700 million.

Solana DEX leaderboard by trading volume | Source: DeFiLlama

The Rise of Dark Pools on Solana
Prop AMMs, often described as dark pools, quote prices privately and route trades through aggregators rather than public order books. This results in private execution and reduced slippage, making them attractive to large traders who prefer not to reveal their moves.

Data from Sandwiched.me shows these protocols sometimes achieve negative spreads, allowing exceptionally cost-efficient swaps. This efficiency is leading to a shift from public liquidity venues like Raydium and Orca toward these quieter, algorithm-driven pools.

For instance, HumidiFi lacks a public front end or massive hype of social media, but it is drawing significant flow from professional market participants. The platform’s deep liquidity and private routing allow whales to place large trades without alerting the wider market.

Competition Remains Fierce
While HumidiFi’s numbers impress, established rivals continue to dominate the ecosystem. Raydium remains a leader of Solana’s decentralized exchange scene with its robust liquidity, consistent technical development, and community incentives.

Meteora also retains a strong market share through extensive integrations and partnerships. On the other hand, PumpSwap serves retail traders seeking quick Solana meme coins opportunities.

Meanwhile, the broader decentralized space continues to record growth. Decentralized-to-centralized exchange trading volumes now hold 18.5% share, which suggests rising interest in non-custodial platforms.

On Solana specifically, weekly decentralized trading climbed 6%, sitting at $2.7 billion as of Sept. 29.

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Solana (SOL) News, Cryptocurrency News, News

A crypto journalist with over 5 years of experience in the industry, Parth has worked with major media outlets in the crypto and finance world, gathering experience and expertise in the space after surviving bear and bull markets over the years. Parth is also an author of 4 self-published books.

Parth Dubey on LinkedIn

Bitcoin ETFs recorded $903 million in outflows, while ether ETFs logged $796 million in redemptions during the week of September 22–26. Fidelity and Blackrock were at the center of the storm, driving the sharpest weekly declines since summer.

MrBeast has reportedly accumulated 705,821 Aster tokens at a collective value of $1.28 million.
ASTER price surged by 7.38% over the last 24 hours, and was last seen being traded at $1.94.
The price of Aster token is estimated to undergo a correction in the short term.

MrBeast has accumulated over 705k Aster tokens in separate transactions. They were collectively worth more than $1 million after the recent transaction was reported. Such an accumulation has sparked bullish sentiments, which are also supported by the constant rise in ASTER price. However, it remains to be seen how long these gains will last for the Aster token.

MrBeast Accumulated Aster Token
MrBeast, one of the richest & most followed content creators across the globe, has accumulated 705,821 Aster tokens. They were collectively valued at around $1.28 million when the report surfaced earlier today. MrBeast accumulated every Aster token in separate transactions.

He bought 538,384 Aster tokens over 3 days for a total value of approximately $990k. It is estimated that the average ASTER price was $1.87 at that time. MrBeast first deposited 1 million USDT via public wallet plus new wallet into the ecosystem. And then, he withdrew Aster tokens for the said average price.

The follow-up report highlighted that he bought 167,436 Aster tokens by spending an additional 320,587 USDT coins. This transaction was executed earlier today to take his holdings above 705k.

MrBeast now reportedly holds 705,821 Aster tokens worth approximately $1.28 million. It is anticipated that the accumulation by the content creator is strategic in nature ahead of significant gains.

ASTER Price Marks Gains
ASTER price is currently up by 7.38% over the last 24 hours, trading at $1.94 when the article is being drafted. The price further reflects a surge of 27.3% and 2182.55% in the last 7 days and 30 days, respectively. The 24-hour trading volume is currently down by 8.29%, possibly demonstrating the intention to keep holdings as they are.

It was earlier reported that many whales were on an ASTER accumulation spree. The action happened around the time when the price of Aster tokens plunged by almost 6% over the past 24 hours. Accumulation of such kinds, reportedly, happened after the token achieved its all-time high value of $2.42 on September 24, 2025.

What’s Next for ASTER Price?
Accumulation of Aster tokens by whale wallets and MrBeast has certainly triggered bullish sentiments around it. However, short-term ASTER price prediction estimates the token to undergo a correction. Aster tokens are expected to decline by 25.72% in the next 30 days. This would take its trading value to around $1.47.

The next 5 days are expected to see the token decline by almost 23.80%, bringing up an approximate value of $1.51. A broader image underlines that ASTER price could hover within a defined range of $1.4 and $1.6, with two extreme ends likely to be $1.50 and $2.20.

It is important to note that the contents of this article are neither recommendations nor advice for crypto trading and investment. Do thorough research and risk assessment.

Highlighted Crypto News Today:

Pump.fun (PUMP) Surge Alert: Uptrend to $0.0060 or Will It Hit a Wall?

Curious by nature, Ankur's core topic is Web3, but he's a versatile writer who can cover many more subjects. If you catch up with him in his free time, you'll find discussions often center around different movies and TV series. He's an easy person to talk to—you can literally chat with him about anything.

WazirX, the Indian cryptocurrency exchange hacked in July 2024 for $234.9 million, has said that it is complying with the order passed by the Singapore High Court. On September 26, the exchange filed its last written statement, following the court-mandated deadline in the restructuring case that was attached to the cyberattack.

The previous deadline from the creditors to correct affidavits expired on September 19, which was followed by Zettai Pte Ltd’s response on September 22nd. Also, both WazirX’s Singapore entity and non-party creditors had due dates to file their last submissions by September 26. The court will now examine these filings and will schedule hearings.

WazirX said it will abide by any legal pronouncement and will continue to keep its customers updated in the process.

WazirX hack fallout leads to legal restructuring
The July 2024 breach was a major turning point for the exchange. Hackers targeted the Safe Multisig wallet and stole assets worth almost $235 million; subsequent investigations blamed North Korean hackers for the attack. In the aftermath, WazirX froze both cryptocurrency and Indian rupee withdrawals.

To limit the financial impact, the exchange is pursuing a scheme of arrangement under the supervision of the courts in Singapore. The process is intended to restructure obligations without interfering with operational continuity. WazirX’s legal proceedings in Singapore are central to the case and involve the Singaporean entity that operates as WazirX, Zettai Pte Ltd, which is in charge of the crypto-to-crypto market. 

Additionally, non-party creditors have been invited to make their position known as the restructuring plan rolls out. This court decision also emphasizes regulatory oversight, as judges asked some of the creditors to resubmit affidavits after their initial filings did not satisfy regulatory requirements. 

Next steps in the court process
With all submissions now filed, the High Court is likely to fix a hearing date. The decision will impact the future of WazirX’s restructuring strategy, which aims to balance creditor claims with the exchange’s ability to recover and rebuild.

In a recent update, WazirX reported that 95.7% of scheme creditors and 94.6% of approved claims voted in favor of its amended restructuring proposal. The results were also independently confirmed by Alvarez & Marsal (SE Asia) Pte Ltd’s Joshua Taylor and Henry Anthony Chambers, who found there to be solid support for the adjusted plan.

The revised timetable reflects the court’s attempts to simplify the process so that creditors and WazirX have an even playing field to present their cases. For customers, the next phase will allow clarity on the extent to which compensation or recovery measures can be put in place under the scheme of arrangement.

Despite the ongoing legal proceedings, WazirX has emphasized its commitment to rebuilding user trust. The exchange noted, “We truly value your patience and support. Thank you for standing by us.”

Get up to $30,050 in trading rewards when you join Bybit today

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

With a 0% change in its exchange reserve metric over the past day, Shiba Inu is displaying a rare sign of inactivity on the exchange front. This essentially means that there have been no significant SHIB inflows or outflows across exchanges, reversing a trend that usually increases price volatility.

Shiba Inu: No movement?Stasis in reserves frequently indicates market indecision because neither buyers nor sellers are intervening forcefully enough to change the balance. At the moment, SHIB is trading close to $0.0000119, which is the lower edge of a conventional symmetrical triangle.

SHIB/USDT Chart by TradingViewFor months, the price has been compressing inside this structure, which is indicated by rising support from the summer lows and falling resistance from the highs. SHIB is currently testing the lower trendline, indicating that the consolidation phase is nearing a turning point.

HOT Stories

On-chain dynamicIt appears that traders are hesitant to make large commitments until SHIB confirms its next breakout direction, as evidenced by the fact that exchange reserves froze at 84.57 trillion tokens. Other on-chain data, however, does indicate some slight activity: transaction counts increased by +1.24%, and token transfers increased by +1.48%. However, the price momentum remains muted and does not reflect these marginal increases.

This hesitation is also reflected in the chart’s thinning volume. While not yet in oversold territory, the RSI, which is at 41, indicates a bearish bias. Regaining the cluster of moving averages above (50 EMA, 100 EMA and 200 EMA) would be required for any bullish reversal attempt, while a clear breakdown below support at 0.0000110 might pave the way for a move toward 0.0000090.

One way or another, SHIB is stagnant on the charts and the chain. Both buyers and sellers are marginalized, as evidenced by the 0% change in the exchange reserve. When this lull ends, traders should brace themselves for volatility, but for the time being, Shiba Inu is essentially stagnant.